Zoetis, Inc. (ZTS)
82.11
-7.09
(-7.95%)
USD |
NYSE |
Nov 05, 16:00
81.25
-0.86
(-1.05%)
Pre-Market: 06:02
Zoetis Net Income (TTM)
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.616B |
| March 31, 2026 | 2.651B |
| December 31, 2025 | 2.652B |
| September 30, 2025 | 2.63B |
| June 30, 2025 | 2.601B |
| March 31, 2025 | 2.499B |
| December 31, 2024 | 2.496B |
| September 30, 2024 | 2.438B |
| June 30, 2024 | 2.342B |
| March 31, 2024 | 2.388B |
| December 31, 2023 | 2.34B |
| September 30, 2023 | 2.277B |
| June 30, 2023 | 2.209B |
| March 31, 2023 | 2.068B |
| December 31, 2022 | 2.111B |
| September 30, 2022 | 2.064B |
| June 30, 2022 | 2.088B |
| March 31, 2022 | 2.07B |
| December 31, 2021 | 2.034B |
| September 30, 2021 | 1.979B |
| June 30, 2021 | 1.906B |
| March 31, 2021 | 1.771B |
| December 31, 2020 | 1.636B |
| September 30, 2020 | 1.662B |
| June 30, 2020 | 1.616B |
| Date | Value |
|---|---|
| March 31, 2020 | 1.611B |
| December 31, 2019 | 1.50B |
| September 30, 2019 | 1.461B |
| June 30, 2019 | 1.375B |
| March 31, 2019 | 1.386B |
| December 31, 2018 | 1.424B |
| September 30, 2018 | 1.159B |
| June 30, 2018 | 1.108B |
| March 31, 2018 | 973.00M |
| December 31, 2017 | 862.00M |
| September 30, 2017 | 936.00M |
| June 30, 2017 | 877.00M |
| March 31, 2017 | 854.00M |
| December 31, 2016 | 819.00M |
| September 30, 2016 | 685.00M |
| June 30, 2016 | 638.00M |
| March 31, 2016 | 378.00M |
| December 31, 2015 | 339.00M |
| September 30, 2015 | 445.00M |
| June 30, 2015 | 422.00M |
| March 31, 2015 | 597.00M |
| December 31, 2014 | 587.00M |
| September 30, 2014 | 565.00M |
| June 30, 2014 | 529.00M |
| March 31, 2014 | 518.00M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Merck & Co., Inc. | 2.449B |
| Phibro Animal Health Corp. | -- |
| Eli Lilly & Co. | 27.58B |
| Pfizer Inc. | 4.074B |
| Bristol Myers Squibb Co. | 9.242B |